Načítá se...
The Exeter™ Universal Hip in Patients 50 Years or Younger at 10–17 Years’ Followup
The Exeter™ Universal hip (Stryker Inc., Newbury, UK) has reported survival rates of 91.74% at 12 years in all patients with reoperation as an endpoint. However, its performance in younger patients has not been fully established. We reviewed survivorship and the clinical and radiographic outcomes of...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer-Verlag
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2505153/ https://ncbi.nlm.nih.gov/pubmed/18196413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11999-007-0049-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|